Mid Atlantic Financial Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$3.69M Sell
62,357
-733
-1% -$48.3K 0.25% 86
2021
Q2
$4.22M Sell
63,090
-3,088
-5% -$201K 0.28% 76
2021
Q1
$4.18M Buy
66,178
+2,550
+4% +$159K 0.31% 75
2020
Q4
$3.95M Buy
63,628
+10,896
+21% +$670K 0.3% 77
2020
Q3
$3.38M Sell
52,732
-1,703
-3% -$102K 0.3% 78
2020
Q2
$3.2M Buy
54,435
+1,634
+3% +$97.7K 0.31% 72
2020
Q1
$2.94M Buy
52,801
+2,217
+4% +$136K 0.34% 65
2019
Q4
$3.25M Buy
50,584
+10,354
+26% +$593K 0.3% 78
2019
Q3
$2.04M Sell
40,230
-19
-0% -$893 0.22% 93
2019
Q2
$1.82M Sell
40,249
-2,076
-5% -$96.7K 0.19% 111
2019
Q1
$2.02M Buy
42,325
+1,082
+3% +$53.9K 0.22% 95
2018
Q4
$2.14M Buy
+41,243
New +$2.22M 0.27% 82

Other funds holding BMY

Mid Atlantic Financial Management's BMY Position: Q3 2021 in Review

Mid Atlantic Financial Management reduced its Bristol-Myers Squibb (BMY) stake by 1.2% in Q3 2021, selling an estimated $48.3K and leaving 62,357 shares worth $3.69M. The position accounts for 0.25% of the portfolio, ranked #86.

Mid Atlantic Financial Management first reported a position in BMY in Q4 2018 and has held it in 12 quarters since. The position peaked at $4.22M in Q2 2021. 2,292 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

  • Mid Atlantic Financial Management held 62,357 shares of Bristol-Myers Squibb worth $3.69M as of Q3 2021.
  • Mid Atlantic Financial Management sold 733 Bristol-Myers Squibb shares in Q3 2021, an estimated $48.3K.
  • Bristol-Myers Squibb made up 0.25% of Mid Atlantic Financial Management's portfolio in Q3 2021, its #86 holding.
  • Mid Atlantic Financial Management first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 12 quarters since.
  • Mid Atlantic Financial Management's Bristol-Myers Squibb position peaked at $4.22M in Q2 2021.
  • 2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.